Desk›Chemicals› Astec Lifesciences Ltd
Astec Lifesciences Ltd
BSE 533138 · NSE ASTEC · ISIN INE563J01010 · Group B · Active
Commodities › Chemicals › Fertilizers & Agrochemicals › Pesticides & Agrochemicals
₹585.75
-1.10%
BSE close, 28 August 2026
₹1,305.22 cr
2.2 cr shares · Micro cap
₹364.66 cr
as published
-19.6× · 4.49×
EPS ₹-29.93 · BV ₹130.46
448.15 / -81.01
₹ cr, as filed
18
3 selected · 17%
Reg 30
Sch. III Part A
Price 52-week, BSE
| Against 52-week high | -37.4% |
|---|---|
| Against 52-week low | +14.3% |
| Day change | -1.10% |
| Size band | Micro cap |
| Index membership | None |
Valuation as published by BSE
| Earnings per share | ₹-29.93 |
|---|---|
| Price / earnings | -19.57× |
| Price / book | 4.49× |
| Book value — derived, price ÷ P/B | ₹130.46 |
| Return on equity | -22.93% |
| Operating margin | 0.06% |
| Net margin | -22.42% |
Consistency check
- P/B ÷ P/E, which must equal ROE
- -22.94%
- ROE as published
- -22.93%
Results ₹ crore, as filed
RevenueNet profit one scale across all three periods, ₹ crore
| Period | Revenue ₹cr | Net profit ₹cr | EPS ₹ | OPM | NPM |
|---|---|---|---|---|---|
| Jun-26 · Q | 83.56 | -18.74 | -8.41 | 0.06% | -22.42% |
| Mar-26 · Q | 158.62 | -7.78 | -3.49 | 7.42% | -4.91% |
| FY25-26 | 448.15 | -81.01 | -37.83 | -0.36% | -18.08% |
Quarter on quarter
- Revenue, quarter on quarter
- -47.3%
- Net profit, quarter on quarter
- -140.9%
- Operating margin, quarter on quarter
- -736 bps
Disclosure profile 18 filings in the window
| Tag | Filings |
|---|---|
| Selected | |
| Board Outcome | 1 |
| Press Release | 1 |
| Results | 1 |
| Selected sub-total | 3 |
| Procedural | |
| General | 6 |
| Clarification | 4 |
| AGM / EGM | 2 |
| Board Meeting | 1 |
| Compliance Certificate | 1 |
| Trading Window | 1 |
| Procedural sub-total | 15 |
| Total | 18 |
Disclosure regime
LODR Reg 30
Read with Schedule III Part A. An equity filer in BSE Group B, so the Regulation 30 disclosure framework and the Schedule III event list both apply.
Filing rhythm · 93 trading days
18 filings · 3 selected · busiest 2026-07-31
Filing rhythm · the twelve most recent
2026-07-312026-10-08
SelectedProcedural
Filings
18 in the window · 10 earlier on record
-
8 October 2026 ·
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed, certificate for the Quarter ended September 30, 2026.
Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 View filing →
-
1 October 2026 ·
Response To Volume Movement Letter
Please find enclosed, Company's response.
Company Update / General View filing →
-
1 October 2026 ·
Clarification sought from Astec Lifesciences Ltd
The Exchange has sought clarification from Astec Lifesciences Ltd on October 1, 2026, with reference to Movement in Volume. The reply is awaited.
Company Update / Clarification
-
28 September 2026 ·
Closure of Trading Window
Please find enclosed, intimation of closure of trading window.
Insider Trading / SAST / Closure of Trading Window View filing →
-
18 September 2026 ·
Response To BSE Query Dated 18.09.2026
Please find enclosed, Company's response.
Company Update / General View filing →
-
18 September 2026 ·
Clarification sought from Astec Lifesciences Ltd
The Exchange has sought clarification from Astec Lifesciences Ltd on September 18, 2026, with reference to Movement in Volume. The reply is awaited.
Company Update / Clarification
-
11 September 2026 ·
Response To BSE E-Mail Seeking Clarification On Price Movement
Please find enclosed, our response to BSE e-mail dated September 10, 2026.
Company Update / General View filing →
-
10 September 2026 ·
Clarification sought from Astec Lifesciences Ltd
The Exchange has sought clarification from Astec Lifesciences Ltd on September 10, 2026 with reference to significant movement in price, in order to ensure that investors have latest relevant ....
Company Update / Clarification
-
9 September 2026 ·
Reply To BSE Query Regarding Volume Movement Dated September 9, 2026
Please find enclosed, our response.
Company Update / General View filing →
-
9 September 2026 ·
Clarification sought from Astec Lifesciences Ltd
The Exchange has sought clarification from Astec Lifesciences Ltd on September 09, 2026, with reference to Movement in Volume. The reply is awaited.
Company Update / Clarification
-
31 July 2026 ·
Shareholder Meeting / Postal Ballot-Scrutinizer's Report
Please find enclosed, AGM proceedings, Scrutinizer's Report, Annual Report and Voting Results.
AGM/EGM / AGM View filing →
-
31 July 2026 ·
Shareholder Meeting / Postal Ballot-Outcome of AGM
Please find enclosed, AGM proceedings, Scrutinizer's Report, Annual Report and Voting Results.
AGM/EGM / AGM View filing →
-
31 July 2026 ·
32Nd Annual General Meeting
Please find enclosed, AGM proceedings, Scrutinizer's Report, Annual Report and Voting Results.
Company Update / General View filing →
-
31 July 2026 ·
32Nd Annual General Meeting
Please find enclosed AGM Proceeding, Scrutinizer Report, Annual Report, Voting Results.
Company Update / General View filing →
-
31 July 2026 ·
Press Release / Media Release
Please find attached Press Release dated 31st July 2026
Company Update / Press Release / Media Release View filing →
-
31 July 2026 ·
Financial Result For The Quarter Ended June 30, 2026
Please find attached the financial results for the Quarter ended June 30, 2026
Result / Financial Results View filing →
-
31 July 2026 ·
Board Meeting Outcome for Outcome Of Board Meeting
Please find attached the Outcome of Board Meeting
Board Meeting / Outcome of Board Meeting View filing →
-
21 July 2026 ·
Board Meeting Intimation for Intimation Of Board Meeting
Astec Lifesciences Ltd has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 31/07/2026 ,inter alia, to consider and approve Standalone and Consolidated ....
Board Meeting / Board Meeting View filing →
RSS feed for Astec Lifesciences Ltd · the 50 most recent filings